Small Pharma Stock Forecast, Price & News

-0.02 (-3.09 %)
(As of 07/28/2021 11:55 AM ET)
Today's Range
50-Day Range N/A
52-Week Range
Volume39,257 shs
Average Volume96,025 shs
Market CapitalizationC$148.90 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive DMT News and Ratings via Email

Sign-up to receive the latest news and ratings for Small Pharma and its competitors with MarketBeat's FREE daily newsletter.

About Small Pharma

Small Pharma Ltd. operates as a pharmaceutical company that develops a rapid-acting antidepressant to treat patients with depression. The company was founded in 2015 and is based in London, United Kingdom.


Small Pharma (CVE:DMT) Trading Up 11.1%
Small Pharma (CVE:DMT) Trading Up 11.1%
July 13, 2021 |
See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

0.00 out of 5 stars

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Small Pharma (CVE:DMT) Frequently Asked Questions

What stocks does MarketBeat like better than Small Pharma?

Wall Street analysts have given Small Pharma a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Small Pharma wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are Small Pharma's key executives?

Small Pharma's management team includes the following people:
  • Mr. Peter David Rands, CEO, MD & Director
  • Ms. Marie Claire Layzell, COO, Head of CMC & Director
  • Ms. Carol Routledge, Chief Scientific & Medical Officer
  • Mr. Jim Rennie, Director of Devel. and Member of Scientific & Advisory Board

Who are some of Small Pharma's key competitors?

What is Small Pharma's stock symbol?

Small Pharma trades on the Canadian Venture Exchange (CVE) under the ticker symbol "DMT."

How do I buy shares of Small Pharma?

Shares of DMT and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Small Pharma's stock price today?

One share of DMT stock can currently be purchased for approximately C$0.47.

How much money does Small Pharma make?

Small Pharma has a market capitalization of C$148.90 million and generates C$45,000.00 in revenue each year.

What is Small Pharma's official website?

The official website for Small Pharma is

How can I contact Small Pharma?

The company can be reached via phone at 44 78 1212 1944.

This page was last updated on 7/29/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.